 AUSTIN, Texas, Feb. 04, 2021 GLOBE NEWSWIRE -- Aspira Womens Health Inc. Nasdaq: AWH Aspira, a bio-analytical based womens health company focused on gynecologic disease, today announced the pricing of the previously announced underwritten public offering of 6,000,000 shares of its common stock at a price to the public of 7.50 per share. In addition, Aspira has granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares are being offered by Aspira. 